Surveillance and treatment of periampullary and duodenal adenomas in familial adenomatous polyposis

Current Treatment Options in Gastroenterology

Volumn 7, Issue 2, 2004, Pages 79-89

  Johnson, J Chad ^b   DiSario, James A ^b   Grady, William M ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; CALCIUM; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; ERGOCALCIFEROL; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE INHIBITOR; SULINDAC;

ADENOCARCINOMA; ADENOMATOUS POLYP; ADVANCED CANCER; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; CANCER SURGERY; CAUSE OF DEATH; CHEMOPROPHYLAXIS; CLINICAL TRIAL; COLON RESECTION; DESMOID TUMOR; DIARRHEA; DISEASE ACTIVITY; DRUG COST; DRUG EFFICACY; DRUG SELECTIVITY; DUODENUM POLYP; DUODENUM TUMOR; ENDOSCOPY; ESOPHAGITIS; FAMILIAL POLYPOSIS; GASTROINTESTINAL HEMORRHAGE; HUMAN; KIDNEY FAILURE; LIFESPAN; NAUSEA; PANCREATICODUODENECTOMY; PERIPHERAL EDEMA; POSTOPERATIVE COMPLICATION; PRECANCER; PROGNOSIS; PROPHYLAXIS; PROSPECTIVE STUDY; REMISSION; REVIEW; RISK ASSESSMENT; SCREENING; ULCER; VATER PAPILLA; VOMITING;

EID: 3142667586     PISSN: 10928472     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11938-004-0028-y     Document Type: Review

References (57)

1. Funkenstein O: Uber polyposis intestinalis. Zeitschrift fur Klinische Medizinische Berlin 1904, 55:236-248.
2. Offerhaus GJ, Giardiello FM, Krush AJ, et al.: The risk of upper gastrointestinal cancer in familial adenomatous polyposis. Gastroenterology 1992, 102:1980-1982.
3. Bulow S, Alm T, Fausa O, et al.: Duodenal adenomatosis in familial adenomatous polyposis. DAF Project Group. Int J Colorectal Dis 1995, 10:43-46.
4. Domizio P, Talbot IC, Spigelman AD, et al.: Upper gastrointestinal pathology in familial adenomatous polyposis: results from a prospective study of 102 patients. J Clin Pathol 1990, 43:738-743.
5. Wallace MH, Phillips RK: Upper gastrointestinal disease in patients with familial adenomatous polyposis. Br J Surg 1998, 85:742-750.
6. Spigelman AD, Williams CB, Talbot IC, et al.: Upper gastrointestinal cancer in patients with familial adenomatous polyposis. Lancet 1989, 2:783-785.
7. Church JM, McGannon E, Hull-Boiner S, et al.: Gastroduodenal polyps in patients with familial adenomatous polyposis. Dis Colon Rectum 1992, 35:1170-1173.
8. Moozar KL, Madlensky L, Berk T, Gallinger S: Slow progression of periampullary neoplasia in familial adenomatous polyposis. J Gastrointest Surg 2002, 6:831-837; discussion 837.
9. Burke CA, Beck GJ, Church JM, van Stolk RU: The natural history of untreated duodenal and ampullary adenomas in patients with familial adenomatous polyposis followed in an endoscopic surveillance program. Gastrointest Endosc 1999, 49:358-364.
10. Groves CJ, Saunders BP, Spigelman AD, Phillips RK: Duodenal cancer in patients with familial adenomatous polyposis (FAP): results of a 10 year prospective study. Gut 2002, 50:636-641.
11. Bjork J, Akerbrant H, Iselius L, et al.: Periampullary adenomas and adenocarcinomas in familial adenomatous polyposis: cumulative risks and APC gene mutations. Gastroenterology 2001, 121:1127-1135.
12. Jagelman DG, DeCosse JJ, Bussey HJ: Upper gastrointestinal cancer in familial adenomatous polyposis. Lancet 1988, 1:1149-1151.
13. Heiskanen I, Kellokumpu I, Jarvinen H: Management of duodenal adenomas in 98 patients with familial adenomatous polyposis. Endoscopy 1999, 31:412-416.
14. Pauli RM, Pauli ME, Hall JG: Gardner syndrome and periampullary malignancy. Am J Med Genet 1980, 6:205-219.
15. Matsumoto T, Iida M, Nakamura S, et al.: Depressed adenoma of the duodenum in patients with familial adenomatous polyposis: endoscopic and immunohistochemical features. Cancer 1999, 86:1414-1420.
16. Decosse JJ, Miller HH, Lesser ML: Effect of wheat fiber and vitamins C and E on rectal polyps in patients with familial adneomatous polyposis. J Natl Cancer Inst 1989, 6:1290-1297.
17. Hioki K, Shivapurkar N, Oshima H, et al.: Suppression of intestinal polyp development by low-fat and high-fiber diet in Apc (delta716) knockout mice. Carcinogenesis 1997, 18:1863-1865.
18. Oshima M, Dinchuk JE, Kargman SL, et al.: Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 1996, 87:803-809.
19. Steinbach G, Lynch PM, Phillips RK, et al.: The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 2000, 342:1946-1952.
20. Giardiello FM, Offerhaus JA, Tersmette AC, et al.: Sulindac induced regression of colorectal adenomas in familial adenomatous polyposis: evaluation of predictive factors. Gut 1996, 38:578-581.
21. Phillips RK, Wallace MH, Lynch PM, et al.: A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis. Gut 2002, 50:857-860.
22. Bussey HJ, DeCosse JJ, Deschner EE, et al.: A randomized trial of ascorbic acid in polyposis coli. Cancer 1982, 50:1434-1439.
23. Seow-Choen F, Vijayan V, Keng V: Prospective randomized study of sulindac versus calcium and calciferol for upper gastrointestinal polyps in familial adenomatous polyposis. Br J Surg 1996, 83:1763-1766.
24. Thomas MG, Thomson JP, Williamson RC: Oral calcium inhibits rectal epithelial proliferation in familial adenomatous polyposis. Br J Surg 1993, 80:499-501.
25. Richard CS, Berk T, Bapat BV, et al.: Sulindac for periampullary polyps in FAP patients. Int J Colorectal Dis 1997, 12:14-18.
26. Nugent KP, Farmer KC, Spigelman AD, et al.: Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis. Br J Surg 1993, 80:1618-1619.
27. Debinski HS, Trojan J, Nugent KP, et al.: Effect of sulindac on small polyps in familial adenomatous polyposis. Lancet 1995, 345:855-856.
28. Vasen HF, Bulow S, Myrhoj T, et al.: Decision analysis in the management of duodenal adenomatosis in familial adenomatous polyposis. Gut 1997, 40:716-719.
29. Dunlop MG: Guidance on gastrointestinal surveillance for hereditary non-polyposis colorectal cancer, familial adenomatous polypolis, juvenile polyposis, and Peutz-Jeghers syndrome. Gut 2002, 51 (suppl 5):V21-V27.
30. Burt RW: Gastric fundic gland polyps. Gastroenterology 2003, 125:1462-1469.
31. Bertoni G, Sassatelli R, Tansini P, et al.: Jejunal polyps in familial adenomatous polyposis assessed by push-type endoscopy. J Clin Gastroenterol 1993, 17:343-348.
32. Burt RW: Colon cancer screening. Gastreoenterology 2000, 11:837-853.
33. Norton ID, Geller A, Petersen BT, et al.: Endoscopic surveillance and ablative therapy for periampullary adenomas. Am J Gastroenterol 2001, 96:101-106.
34. Alarcon FJ, Burke CA, Church JM, van Stolk RU: Familial adenomatous polyposis: efficacy of endoscopic and surgical treatment for advanced duodenal adenomas. Dis Colon Rectum 1999, 42:1533-1536.
35. Ghilain JM, Dive C: Endoscopic laser therapy for small villous adenomas of the duodenum. Endosocopy 1994, 26:308-310.
36. Ahmad NA, Kochman ML, Long WB, et al.: Efficacy, safety and clinical outcomes of endoscopic mucosal resection: as study of 101 cases. Gastrointest Endosc 2002, 55:390-396.
37. DiSario J, Samowitz W, Burt R, Kuwada S: Endoscopic therapy of large gastroduodenal polyps in familial adenomatous polyposis. Gastrointest Endosc 2002, 55:AB138.
38. Cotton PB, Lehman G, Vennes J, et al.: Endoscopic sphincterotomy commplications and their management: an attempt at consensus. Gastrointestinal Endosc 1991, 37:383-393.
39. Binmoeller KF, Boaventura S, Ramsperger K, Soehendra N: Endoscopic snare excision of benign adenomas fo the papilla of Vater. Gastrointest Endosc 1993, 39:127-131.
40. Desilets DJ, Dy RM, Ku PM, et al.: Endoscopic management of tumors of the major duodenal papilla: refined techniques to improve outcome and avoid complications. Gastrointest Endosc 2001, 54:202-208.
41. Park SW, Song SY, Chung JB, et al.: Endoscopic snare resection for tumors of the ampulla of Vater. Yonsei Med J 2000, 41213-41218.
42. Zadorova Z, Dvofak M, Hajer J: Endoscopic therapy of benign tumors of the papilla of Vater. Endoscopy 2001, 33:345-347.
43. Bleau BL, Gostout CJ: Endoscopic treatment of ampullary adenomas in familial adenomatous polyposis. J Clin Gastroenterol 1996, 22:237-241.
44. DiSario JA, Giampaolo A, Samowitz WS, Burt RW: Endoscopic management of ampulla of Vater lesions in familial adenomatous polyposis. Gut 2002, 51(suppl III):A278.
45. Regula J, MacRobert AJ, Gorchein A, et al.: Photosensitisation and photodynamic therapy of oesophageal, duodenal, and colorectal tumours using 5 aminolaevulinic acid induced protoporphyrin IX - a pilot study. Gut 1995, 36:67-75.
46. Mkvy P, Messmann H, Debinski H, et al.: Photodynamic therapy for polyps in familial adenomatous polyposis - a pilot study. Eur J Cancer 1995, 31A:1160-1165.
47. Penna C, Phillips RK, Tiret E, Spigelman AD: Surgical polypectomy of duodenal adenomas in familial adenomatous polyposis: experience of two European centres. Br J Surg 1993, 80:1027-1029.
48. Penna C, Bataille N, Balladur P, et al.: Surgical treatment of severe duodenal polyposis in familial adenomatous polyposis. Br J Surg 1998, 85:665-668.
49. Cameron JL, Pitt HA, Yeo CJ, et al.: One hundred and forty-five consecutive pancreaticoduodenectomies without mortality. Ann Surg 1993, 217:430-435; discussion 435-438.
50. Barens SA, Lillemoe KD, Kaufman HS, et al.: Pancreaticoduodenectomy for benign disease. Am J Surg 1996, 171:131-134; discussion 134-135.
51. Sosa JA, Bowman HM, Gordon TA, et al.: Importance of hospital volume in the overall management of pancreatic cancer. Ann Surg 1998, 228:429-438.
52. Ruo L, Coit DG, Brennan MF, Guillem JG: Long-term follow-up of patients with familial adenomatous polyposis undergoing pancreaticoduodenal surgery. J Gastrointest Surg 2002, 6:671-675.
53. Rosemurgy AS, Bloomston M, Serafini FM, et al.: Frequency with which surgeons undertake pancreaticoduodenectomy determines length of stay, hospital charges, and in-hospital mortality. J Gastrointest Surg 2001, 5:21-26.
54. Porter GA, Pisters PW, Mansyur C, et al.: Cost and utilization impact of a clinical pathway for patients undergoing pancreaticoduodenectomy. Ann Surg Oncol 2000, 7:484-489.
55. Lundell L, Hyltander A, Liedman B: Pancreas-sparing duodenectomy: technique and indications. Eur J Surg 2002, 168:74-77.
56. Kalady MF, Clary BM, Tyler DS, Pappas TN: Pancreas-preserving duodenectomy in the management of duodenal familial adenomatous polyposis. J Gastrointest Surg 2002, 6:82-87.
57. Saurin JC, Ligneau B, Ponchon T, et al.: The influence of mutation site and age on the severity of duodenal polyposis in patients with familial adenomatous polyposis. Gastrointest Endosc 2002, 55:342-347.